FDA

Overview

Companies regulated by the FDA face continuous government scrutiny and encounter a range of legal, regulatory and business challenges, whether they are just starting out or have been in operation for decades. Our attorneys are well equipped to help FDA-regulated companies manage these challenges, as we possess a wealth of firsthand knowledge about critical life cycle matters including product development, manufacturing and supply, and commercialization.

Our teams of FDA-focused attorneys collaborate seamlessly across practices encompassing:

  • Intellectual Property
  • Privacy and Data Security
  • Labor and Employment
  • Corporate Law

BakerHostetler attorneys integrate real-world experience and expertise that is both broad and deep. This enables us to tailor our counsel to meet the unique needs of our clients and help them develop strategies to manage risk at all stages of their products’ life cycles.

We work closely with executive management teams; regulatory affairs; compliance and legal departments; corporate boards of directors; private equity funds; medical and safety review committees; and institutional review boards, regularly assisting clients with matters involving:

  • Pharmaceuticals and Biologics
  • Medical Devices and Diagnostics
  • Food and Dietary Supplements
  • Emerging Technologies
  • Cosmetics
  • Tobacco

Select Experience

  • Advised pharmaceutical companies in assessment of and response to safety signals of potentially life threatening conditions.
  • Represented a compounding pharmacy during a recall of compounded medications following FDA and State Board of Pharmacy inspections.
  • Represented a medical device company on product safety positions taken by the Centers for Disease Control and Prevention and healthcare epidemiology societies.
More »

Experience

  • Advised pharmaceutical companies in assessment of and response to safety signals of potentially life threatening conditions.
  • Represented a compounding pharmacy during a recall of compounded medications following a FDA and State Board of Pharmacy inspection.
  • Represented a medical device company on product safety positions taken by the Centers for Disease Control and Prevention and healthcare epidemiology societies.
  • Represented a pharmacy during an FDA inspection of the pharmacy’s compounding area and activities.
  • Advised pharmaceutical, medical device and cosmetic companies on advertising claims that required the assessment of clinical trials.
  • Advised private equity funds during the diligence of both FDA manufacturers and licensed pharmacies.
  • Helped academic medical centers to develop policies and procedures for managing conflicts of interest and apply them in specific research projects.
  • Represented pharmacies and wholesale distributors in front of 50 state boards of pharmacy.
  • Defended pharmaceutical companies in nationwide products liability litigation arising from analgesic, cough-cold and colonoscopy preparation products.

Recognition

  • Chambers USA: Healthcare
    • Florida (2018)
      • Band 4
    • Georgia (2015 to 2018)
      • Band 3
    • Ohio (2011 to 2018)
      • Band 3
    • Texas (2009 to 2018)
      • Band 3
    • Recognized Practitioner in Florida (2016, 2017)
    • Recognized Practitioner Nationwide (2017)
    • Recognized Practitioner Healthcare: Pharmaceutical/Medical Products Regulatory in District of Columbia (2016, 2018)
  • Recognized as one of the top law firms for client service, BakerHostetler was named to the 2020 BTI Client Service 30 for the sixth consecutive year.